Author:
Schwarzenböck Sarah,Souvatzoglou Michael,Krause Bernd J.
Publisher
Springer Berlin Heidelberg
Reference63 articles.
1. Ackerstaff E, Pflug BR, et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 2001;61(9):3599–603.
2. Ackerstaff E, Glunde K, et al. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90(3):525–33.
3. Albrecht S, Buchegger F, et al. (11)C-acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging. 2007;34(2):185–96.
4. Beer AJ, Eiber M, et al. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol. 2011;13(2):352–61.
5. Beheshti M, Vali R, et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging. 2008;35(10):1766–74.